Dyadic International to Present at the 4th International Conference on Biologics and Biosimilars
08 oct. 2015 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI) announced that Dyadic’s Chief Executive Officer Mark Emalfarb will make a presentation titled...
Dyadic Receives C1 Derived Vaccine Test Results From Sanofi Pasteur and Provides Further Details on New EU-Funded ZAPI Biopharmaceutical Program
07 oct. 2015 11h13 HE
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 07, 2015 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of...
Dyadic International Reports Second Quarter 2015 Financial Results
14 août 2015 16h30 HE
|
Dyadic International, Inc.
First Half Revenue Up 30% Year-Over-YearGross Profit Up 50% Year-Over-YearInitial Biogas Enzyme Product Launch in EuropeReceipt of Second and Third BASF Research MilestonesReached and Received a Low...
Dyadic International Announces It Has Reached a Settlement With One of the Three Remaining Defendant Law Firms in Its Professional Liability Litigation
05 août 2015 16h32 HE
|
Dyadic International, Inc.
JUPITER, Fla., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic") (OTCQX:DYAI), today announced it has reached a settlement with one of the three remaining defendant law firms...
Dyadic International to Announce Second Quarter 2015 Financial Results on Friday August 14, 2015 and Host Conference Call on Monday, August 17, 2015
05 août 2015 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop,...
Dyadic International Reports First Quarter 2015 Financial Results
14 mai 2015 16h30 HE
|
Dyadic International, Inc.
Total Revenue up 35% Year-over-YearGross Profit up 70% Year-over-YearAchieved Additional C1 Research & Development Milestones from BASFFour EU Funded Research Programs Approved for Start...